Finding new causes of retinitis pigmentosa using metabolic and protein analysis
Identification of novel contributors to retinitis pigmentosa using metabolic and proteomic approaches
This study is looking at how retinitis pigmentosa affects the eyes at a molecular level in mice, hoping to find clues that could lead to new treatments for people with this condition before they experience serious vision loss.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10694148 on NIH RePORTER |
What this research studies
This research investigates the early molecular mechanisms behind retinitis pigmentosa (RP), a condition that leads to progressive vision loss and blindness. By comparing a specific genetic mouse model of RP with normal mice, the researchers aim to identify key metabolic and proteomic changes that occur before significant cell death and vision impairment. The study utilizes advanced techniques such as metabolomics and proteomics to uncover potential therapeutic targets that could help in treating this debilitating condition. Patients may benefit from insights gained into the disease's progression and potential new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with retinitis pigmentosa or those with a family history of the condition.
Not a fit: Patients with other forms of retinal degeneration unrelated to retinitis pigmentosa may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic targets for treating retinitis pigmentosa, potentially preserving vision for affected patients.
How similar studies have performed: Previous research has shown promise in identifying metabolic changes in other retinal diseases, suggesting that this approach may yield valuable insights for retinitis pigmentosa as well.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Weiss, Ellen Ruth — Univ of North Carolina Chapel Hill
- Study coordinator: Weiss, Ellen Ruth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.